ArticleTranslational stroke research2026
Plasma Tryptophan Hydroxylase 1 Activity-related Metabolic Markers and Stroke Risk: A Nested Case-control Study.
Article in Translational stroke research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Tryptophan hydroxylase 1 (TPH1) has emerged as a therapeutic target for metabolic diseases, but its association with stroke in the general population remains unclear. This study investigated the relationship between TPH1-related metabolic markers and stroke risk. A nested case–control study was conducted within a community-based cohort in China (n = 16,113; 2013–2018), including 412 incident stroke cases and 412 controls matched on age and sex. Plasma levels of tryptophan (Trp), kynurenine (Kyn), and 5-hydroxyindoleacetic acid (5-HIAA) were quantified via ultrahigh-performance liquid chromatography-tandem mass spectrometry. The ratios of 5-HIAA/Trp (as a proxy of TPH1 activity) and 5-HIAA/Kyn were calculated. Conditional logistic regression models were applied to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Higher plasma 5-HIAA/Trp and 5-HIAA/Kyn ratios were significantly associated with an increased risk of total stroke. The corresponding ORs for the highest versus lowest quartile were 2.12 (95% CI: 1.27–3.56, P for trend = 0.003) and 1.90 (95% CI: 1.21–3.00, P for trend = 0.003), respectively. Similar associations were observed for ischemic stroke, with ORs of 2.24 (95% CI: 1.29–3.91, P for trend = 0.004) and 2.11 (95% CI: 1.25–3.56, P for trend = 0.004), respectively. Plasma 5-HIAA levels alone were also positively associated with the risk of total stroke (OR = 1.46, 95% CI: 0.91–2.36, P for trend = 0.044). This study provides the first epidemiological evidence that the 5-HIAA/Trp ratio and 5-HIAA/Kyn ratio are positively associated with the risk of both total and ischemic stroke in the general population. These findings highlight the potential of these ratios as potential biomarkers for stroke risk assessment and TPH1-related metabolism as promising targets for preventive interventions.
Indexed as
Identifiers
42033575What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.